Order Total (1 Item Items):
Shipping Destination:
Kane Gill (34 results)
Author:
kane gill
Refine with Advanced Search
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (33)
- Magazines & Periodicals (No further results match this refinement)
- Comics (1)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (25)
- As New, Fine or Near Fine (7)
- Very Good or Good (1)
- Fair or Poor (No further results match this refinement)
- As Described (1)
Binding
Collectible Attributes
- First Edition (2)
- Signed (1)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (13)
- Not Print on Demand (21)
Language (1)
Free Shipping
- Free Shipping to U.S.A. (No further results match this refinement)
Seller Location
Seller Rating
-
paperback. Condition: Good. a good solid copy. clean and tight pages. fast and secure shipping.
-
Showcase Presents: Robin the Boy Wonder, Vol. 1
First Edition
Paperback. Condition: Like New. First Edition. A nice paperback graphic novel, clean with a tight binding with and an unmarked text.From a private smoke free collection.Shipping within 24 hours, with a tracking number and delivery confirmation.
-
High- Risk IV Medications in Special Patient Populations.
Language: English
Published by Heidelberg, Springer., 2011
ISBN 10: 0857296051 ISBN 13: 9780857296054
Seller: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germany
Association Member: GIAQ ILAB VDA
Seller rating 4 out of 5 stars
XVI, 260p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Stamped. Sprache: Englisch.
-
Condition: Sehr gut. Zustand: Sehr gut | Seiten: 276 | Sprache: Englisch | Produktart: Bücher | Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.
-
GREEN LANTERN No. 85 Facsimile Edition (Nov. 2019) Verified Signature: NEAL ADAMS - CBCS (like CGC) Graded 9.8 (NM/MINT)
Language: English
Published by DC COMICS, New York, 2019
Comic First Edition Signed
US$ 139.30 10% offUS$ 125.37
US$ 23.00 shipping
Ships from Canada to U.S.A.Quantity: 1 available
Add to basketComic. Condition: New. ADAMS, NEAL : KANE, GILL (illustrator). 1st Edition. Comic - 1st. Print Facsimile Edition - Neal Adams Verified Signature - - CBCS Graded 9.8 (NM/MINT) White Pages - In this award-winning tale from 1971, Green Arrow discovers that his former sidekick, Roy Harper, is hooked on heroin! Plus, Sinestro tries to exert mental control over Hal Jordan in a story originally published in Green Lantern No. 11. Signed by Illustrator(s).
-
Condition: New.
-
High-Risk IV Medications in Special Patient Populations
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 138.36
US$ 19.80 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New.
-
Condition: New. pp. 278.
-
High-Risk IV Medications in Special Patient Populations
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 159.58
US$ 15.82 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
High-Risk IV Medications in Special Patient Populations
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 159.58
US$ 15.82 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Condition: New.
-
Condition: New. pp. 278.
-
US$ 175.16
US$ 16.50 shipping
Ships from United Kingdom to U.S.A.Quantity: 2 available
Add to basketHardcover. Condition: Brand New. 1st edition. 260 pages. 9.75x6.50x0.75 inches. In Stock.
-
High-Risk IV Medications in Special Patient Populations
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 183.55
US$ 19.80 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
-
High-Risk IV Medications in Special Patient Populations
Language: English
Published by Springer London, Springer London, 2011
ISBN 10: 0857296051 ISBN 13: 9780857296054
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal circulation devices, advanced age, pharmacogenetic alterations, hemodynamic instability, or therapeutic hypothermia are particularly challenging. A contributing factor to this is the use of high-risk medications with many administered intravenously (IV). Hypervigilant monitoring of high-risk medications is still essential to prevent patient harm, especially in populations that have dosing challenges, hence, regulatory bodies internationally require active institutional surveillance of high-risk medications. These dosing challenges are a great safety concern, since there is considerable risk of unwanted adverse drug events from overdosing or therapeutic inefficacy from underdosing.High-Risk IV Medications in Special Patient Populations reviews high-risk IV medication dosage considerations for special patient populations and discusses the safety concerns of these medications to aid the clinician in cautious monitoring. The authors provide clinicians with tools to minimize adverse drug events with IV high-risk medications, while maximizing the beneficial clinical effects of these drugs, thus making this book essential reading for all involved with the care of critically ill patients.
-
US$ 172.69
US$ 33.00 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketHardcover. Condition: Like New. Like New. book.
-
Condition: As New. Unread book in perfect condition.
-
Taschenbuch. Condition: Neu. High-Risk IV Medications in Special Patient Populations | Sandra Kane-Gill (u. a.) | Taschenbuch | x | Englisch | 2014 | Springer | EAN 9781447158684 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
High-Risk IV Medications in Special Patient Populations
Language: English
Published by Springer London, Springer London, 2014
ISBN 10: 1447158687 ISBN 13: 9781447158684
Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions.
-
US$ 233.88
US$ 33.00 shipping
Ships from United Kingdom to U.S.A.Quantity: 1 available
Add to basketPaperback. Condition: Like New. Like New. book.
-
Condition: As New. Unread book in perfect condition.
-
Condition: new. Questo è un articolo print on demand.
-
Condition: new. Questo è un articolo print on demand.
-
High-Risk IV Medications in Special Patient Populations
Language: English
Published by Springer London Jun 2011, 2011
ISBN 10: 0857296051 ISBN 13: 9780857296054
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Critically ill patients are at risk for a higher frequency and severity of adverse drug events (ADEs), and special patient populations of the critically ill requiring for instance individualized dosing due to non-average weight, hepatic or renal dysfunction, extracorporeal circulation devices, advanced age, pharmacogenetic alterations, hemodynamic instability, or therapeutic hypothermia are particularly challenging. A contributing factor to this is the use of high-risk medications with many administered intravenously (IV). Hypervigilant monitoring of high-risk medications is still essential to prevent patient harm, especially in populations that have dosing challenges, hence, regulatory bodies internationally require active institutional surveillance of high-risk medications. These dosing challenges are a great safety concern, since there is considerable risk of unwanted adverse drug events from overdosing or therapeutic inefficacy from underdosing.High-Risk IV Medications in Special Patient Populations reviews high-risk IV medication dosage considerations for special patient populations and discusses the safety concerns of these medications to aid the clinician in cautious monitoring. The authors provide clinicians with tools to minimize adverse drug events with IV high-risk medications, while maximizing the beneficial clinical effects of these drugs, thus making this book essential reading for all involved with the care of critically ill patients. 276 pp. Englisch.
-
US$ 106.20
US$ 56.13 shipping
Ships from Germany to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in errorNo book has been published on this topic A resource containing all rele.
-
High-Risk IV Medications in Special Patient Populations
Language: English
Published by Springer London Aug 2014, 2014
ISBN 10: 1447158687 ISBN 13: 9781447158684
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Seller rating 5 out of 5 stars
Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Critical Care Clinicians can use general drug references (Micomedex, Lexicomp) for data on dosing of high-alert medications in special patient populations but these references are not available to all healthcare clinicians, they are expensive and they are not specific to high-alert medications or critically ill patients. Doctors, nurses and pharmacists in the hospital setting will benefit from having one resource with all of this information. The purpose of this reference manual would be to guide critical care clinicians on dosing of high-alert medications in special patient populations. The most important feature of the book will be a summary of primary literature using tables when possible. This will be useful to readers because currently a reference book does not exist that guides clinicians in these difficult dosing decisions. 276 pp. Englisch.
-
US$ 126.38
US$ 56.13 shipping
Ships from Germany to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. The Institute for Safe Medication Practices has developed a list of high-alert medications which are medications at a heightened risk for patient harm when used in errorNo book has been published on this topic A resource containing all rele.
-
US$ 171.40
US$ 8.58 shipping
Ships from United Kingdom to U.S.A.Quantity: 4 available
Add to basketCondition: New. Print on Demand pp. 278 3 Illus. (2 Col.).
-
Condition: New. PRINT ON DEMAND pp. 278.
-
US$ 180.23
US$ 8.58 shipping
Ships from United Kingdom to U.S.A.Quantity: 4 available
Add to basketCondition: New. Print on Demand pp. 278.
